These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25810581)

  • 1. Outcome of neoadjuvant chemotherapy in locally advanced breast cancer: A tertiary care centre experience: Retraction.
    Sirohi B
    Indian J Med Paediatr Oncol; 2015; 36(1):71. PubMed ID: 25810581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction note to four articles published in
    Cui Q
    World J Orthop; 2018 Mar; 9(3):58-59. PubMed ID: 29564215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathologic response following taxane based neoadjuvant chemotherapy in locally advanced breast cancer patients in a tertiary care centre in India.
    Sivasanker M; Sistla SC; Manwar SA; Vivekanandam S
    Indian J Cancer; 2016; 53(2):220-225. PubMed ID: 28071613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Role of Scintimammography in Assessing the Response of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
    World J Nucl Med; 2016; 15(1):75. PubMed ID: 26912988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil [Retraction].
    Int J Clin Exp Pathol; 2016; 9(2):2755. PubMed ID: 29874335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction Note.
    Kowsar Publishing Company
    Iran Red Crescent Med J; 2016 Mar; 18(3):e43586. PubMed ID: 27830082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes.
    Frontiers Editorial Office
    Front Oncol; 2019; 9():324. PubMed ID: 31106154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.
    Sarid D; Ron IG; Sperber F; Stadler Y; Kahan P; Kovner F; Ben-Yosef R; Marmor S; Grinberg Y; Maimon N; Weinstein J; Yaal-Hahoshen N
    Clin Drug Investig; 2006; 26(12):691-701. PubMed ID: 17274676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Response rates following neoadjuvant chemotherapy and breast preserving treatment in patients with locally advanced breast cancer].
    Maráz R; Boross G; Svébis M; Gyánti R; Vizhányó R; Hajnal L; Markó L; Szucs M; Ambrózay E; Lorincz M
    Magy Seb; 2005 Aug; 58(4):225-32. PubMed ID: 16261868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction: Perinatal outcome in pregnancies associated with hypertension: A prospective cohort study in a rural tertiary care teaching hospital of North India.
    Indian J Community Med; 2022; 47(1):155. PubMed ID: 35368496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of efficacy and safety of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience.
    Tiwari A; Gogia A; Deo S; Shukla NK; Mathur S; Sharma DN
    Indian J Cancer; 2017; 54(1):343-346. PubMed ID: 29199719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neo-adjuvant Chemotherapy in Locally Advanced Breast Cancer: A Retrospective Analysis from Tertiary Care Centre.
    Sharma D; Singh G
    Gulf J Oncolog; 2016 Sep; 1(22):51-54. PubMed ID: 28191807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction: Profile of Dermatophytosis in a Tertiary Care Center in Kerala, India.
    Indian J Dermatol; 2019; 64(5):421. PubMed ID: 31543544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Kong D; Wang MH; Yang J; Li L
    Oncotarget; 2017 Feb; 8(8):13747-13753. PubMed ID: 28099918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for locally advanced breast cancer--experience in an Asian tertiary hospital.
    Chong HY; Taib NA; Rampal S; Saad M; Bustam AZ; Yip CH
    Asian Pac J Cancer Prev; 2010; 11(4):913-7. PubMed ID: 21133600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of the relationship between expression of survivin and effects of neoadjuvant chemotherapy in locally advanced breast cancer].
    Fuzhong T; Nan L; Jiajia G; Miao L; Deqi Y
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1319-23. PubMed ID: 18701842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy for locally advanced breast cancer in a malaysian tertiary hospital.
    Azrif M; Ibrahim J; Aslan NM; Fong KV; Ismail F
    Asian Pac J Cancer Prev; 2011; 12(1):157-62. PubMed ID: 21517250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-myb is a gene implicated in cell cycle and proliferation of breast cancer [Retraction].
    Int J Clin Exp Pathol; 2016; 9(2):2754. PubMed ID: 29874331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction.
    Muscles Ligaments Tendons J; 2015; 5(2):56. PubMed ID: 26261780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.